Table 1 Clinical information for the osteosarcoma patients used in the study

From: Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone

Tumour ID

Age (years)

Gender

Site of tumour

Tumour necrosis (%)

Response

G3

15

M

Proximal tibia

100

R

S4

29

F

Sacrum

<5

N

S5

27

F

Proximal humerus

<50

N

S7

39

M

Pelvis

<50

N

M8

24

F

Distal femur

25

N

L9

17

M

Tibia

75

N

W10

14

M

Distal femur

75

N

A13

7

F

Proximal tibia

80

N

M14

67

M

Pelvis

75

N

S15

76

F

Tibia

<90

N

W16

15

F

Proximal Humerus

<90

N

O17

12

M

Distal femur

75

N

M18

18

M

8th rib

98

R

K19

17

M

Proximal tibia

50

N

E20

13

F

Femur

95

R

M21

15

M

Distal femur

95

R

W22

15

F

Femur

80

N

G23

18

M

Distal femur

80

N

F2BR

18

M

Proximal tibia

80

N

A3BR

19

F

Distal femur

80

N

V4BR

16

M

Calcaneum

<5

N

M7BR

14

F

Distal femur

>92

R

T1a

37

F

Proximal tibia

U

U

  1. Response to chemotherapy: R=good response; N=poor response; U=unknown.
  2. aThis patient was used in the comparison between osteosarcoma and non-malignant bone, but not in the chemotherapy response study.